SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-KSB/A
Annual Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
For the fiscal year ended August 31, 1995
Commission file number 0-9065
Golden Pharmaceuticals, Inc.
(Name of small business issuer in its charter)
Colorado 84-0645174
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1313 Washington Avenue Golden, Colorado 80401
(Address of principal executive office) (Zip Code)
Issuer's telephone number (303) 279-9375
Securities registered under Section 12(b) of the Exchange Act: None
Securities registered under Section 12(g) of the Exchange Act:
Common Stock, no par value
(Title of Class)
Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),
and (2) has bensubject to such filing requirements for the past 90 days.
Yes No
Check if there is no disclosure of delinquent filers in response to Item 405
of Regulation S-B not contained in this form, and no disclosure will be
contained to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form
10-KSB or any amendment to this Form 10-KSB.
State issuer's revenues for its most recent fiscal year. $4,412,377
Aggregate market value of the voting stock held by non-affiliates of the
registrant as of November 21, 1995 was $5,479,895. This calculation is
based upon the average of the bid ($.085) and asked ($.12) prices of the
voting stock on November 21, 1995.
The number of shares of common stock outstanding as of November 21,
1995 was 93,963,919.
Transitional Small Business Disclosure Format: Yes No Item
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
registrants financial statements for the year ended August 31, 1995 contained in
its annual report on Form 10-KSB and is qualified in it's entirety by
reference to such financial statements.
</LEGEND>
<S> <C> <C>
<PERIOD-TYPE> YEAR YEAR
<FISCAL-YEAR-END> AUG-31-1995 AUG-31-1994
<PERIOD-END> AUG-31-1995 AUG-31-1994
<CASH> 49,557 94,792
<SECURITIES> 0 0
<RECEIVABLES> 1,484,175 310,307
<ALLOWANCES> (63,700) (1,063)
<INVENTORY> 674,955 52,356
<CURRENT-ASSETS> 2,656,600 952,584
<PP&E> 2,736,714 2,052,181
<DEPRECIATION> (1,659,768) (1,555,033)
<TOTAL-ASSETS> 8,079,905 1,515,489
<CURRENT-LIABILITIES> 2,040,931 428,703
<BONDS> 0 0
<COMMON> 21,288,851 21,246,351
0 0
292,558 292,558
<OTHER-SE> (20,469,509) (21,359,368)
<TOTAL-LIABILITY-AND-EQUITY> 8,079,905 1,515,489
<SALES> 4,412,377 3,451,020
<TOTAL-REVENUES> 4,412,377 3,451,020
<CGS> 2,245,230 1,584,864
<TOTAL-COSTS> 2,245,230 1,584,864
<OTHER-EXPENSES> 1,255,645 1,037,502
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 140,330 83,949
<INCOME-PRETAX> 787,303 752,552
<INCOME-TAX> (91,594) (500,000)
<INCOME-CONTINUING> 878,897 1,252,552
<DISCONTINUED> 0 0
<EXTRAORDINARY> 99,677 76,560
<CHANGES> 0 0
<NET-INCOME> 978,574 1,329,112
<EPS-PRIMARY> .01 .01
<EPS-DILUTED> .01 .01
</TABLE>
